Related Experiment Video
Updated: Sep 12, 2025

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Using Remimazolam to Generate Hemodynamically Stable Burst Suppression: A Case Report and Literature Review
Chin Fung Kelvin Kan1,2, Jacob E Pollard1
1Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Abstract:
Remimazolam is a short-acting benzodiazepine that was approved by the United States Food and Drug Administration (FDA) in 2020 for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 min or less. Given its recent introduction, the use of remimazolam for general anesthesia and monitored anesthesia care (MAC) remains an area of ongoing investigation. In this report, we present the first documented case demonstrating that remimazolam can achieve hemodynamic stable burst suppression in a critically ill patient undergoing emergent craniectomy and aneurysm clipping. Additionally, this manuscript reviews the reported off-label applications of remimazolam in both the operating room and the intensive care unit (ICU) settings.
Insights
Remimazolam, a short-acting benzodiazepine, achieved stable burst suppression in a critically ill patient during emergency surgery. This case highlights its potential use beyond procedural sedation in critical care settings.
Area of Science:
- Anesthesiology
- Critical Care Medicine
- Pharmacology
Background:
- Remimazolam is a short-acting benzodiazepine approved for procedural sedation.
- Its application in general anesthesia and monitored anesthesia care (MAC) is under investigation.
- Critically ill patients present unique challenges for anesthesia management.
Observation:
- A critically ill patient required emergent craniectomy and aneurysm clipping.
- Remimazolam was used to achieve burst suppression during the procedure.
- Hemodynamic stability was maintained throughout the intervention.
Findings:
- Remimazolam successfully induced and maintained hemodynamic stable burst suppression.
- This represents the first documented case of its use in this specific critical care scenario.
- The drug demonstrated a favorable safety and efficacy profile in a high-risk patient.
Implications:
- Remimazolam may be a viable option for anesthesia in critically ill patients undergoing major surgery.
- Further research is warranted to explore its broader applications in intensive care units (ICUs) and operating rooms.
- This case expands the understanding of remimazolam's utility in complex surgical and critical care environments.
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Drug Delivery: Enteral Route
REM Sleep Behavior Disorder
RBD is significantly associated with...
CNS Depressants: Barbiturates and Benzodiazepines

